Evidence map›Paper›PMID 21750082›Full record

Trial reportHaematologica2011

Oxidative stress modulates heme synthesis and induces peroxiredoxin-2 as a novel cytoprotective response in β-thalassemic erythropoiesis.

Lucia De Franceschi, Mariarita Bertoldi, Luigia De Falco, Sara Santos Franco, Luisa Ronzoni, Franco Turrini, Alessandra Colancecco, Clara Camaschella, Maria Domenica Cappellini, Achille Iolascon

Open access · goldAbstract readClinical Trial
In one paragraph

Trial report in Haematologica, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 77 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 1 country.

Lucia De FranceschiDepartment of Medicine, University of Verona, Policlinico GB Rossi, Verona, Italy. lucia.defranceschi@univr.it
Mariarita Bertoldi
Luigia De Falco
Sara Santos Franco
Luisa Ronzoni
Franco Turrini
Alessandra Colancecco
Clara Camaschella
Maria Domenica Cappellini
Achille Iolascon
University of Verona · ITInstitute of Biomembranes, Bioenergetics and Molecular Biotechnologies · ITUniversity of Milan · ITFondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico · ITIRCCS Ospedale San Raffaele · ITUniversity of Turin · IT

Funding

Telethon GGP09044
6 · The paper itself

Abstract

backgroundβ-thalassemic syndromes are inherited red cell disorders characterized by severe ineffective erythropoiesis and increased levels of reactive oxygen species whose contribution to β-thalassemic anemia is only partially understood. DESIGN AND

methodsWe studied erythroid precursors from normal and β-thalassemic peripheral CD34(+) cells in two-phase liquid culture by proteomic, reverse transcriptase polymerase chain reaction and immunoblot analyses. We measured intracellular reactive oxygen species, heme levels and the activity of δ-aminolevulinate-synthase-2. We exposed normal cells and K562 cells with silenced peroxiredoxin-2 to H(2)O(2) and generated a recombinant peroxiredoxin-2 for kinetic measurements in the presence of H(2)O(2) or hemin.

resultsIn β-thalassemia the increased production of reactive oxygen species was associated with down-regulation of heme oxygenase-1 and biliverdin reductase and up-regulation of peroxiredoxin-2. In agreement with these observations in β-thalassemic cells we found decreased heme levels related to significantly reduced activity of the first enzyme of the heme pathway, δ-aminolevulinate synthase-2 without differences in its expression. We demonstrated that the activity of recombinant δ-aminolevulinate synthase-2 is inhibited by both reactive oxygen species and hemin as a protective mechanism in β-thalassemic cells. We then addressed the question of the protective role of peroxiredoxin-2 in erythropoiesis by exposing normal cells to oxidative stress and silencing peroxiredoxin-2 in human erythroleukemia K562 cells. We found that peroxiredoxin-2 expression is up-regulated in response to oxidative stress and required for K562 cells to survive oxidative stress. We then showed that peroxiredoxin-2 binds heme in erythroid precursors with high affinity, suggesting a possible multifunctional cytoprotective role of peroxiredoxin-2 in β-thalassemia.

conclusionsIn β-thalassemic erythroid cells the reduction of δ-aminolevulinate synthase-2 activity and the increased expression of peroxiredoxin-2 might represent two novel stress-response protective systems.

Indexed as

ErythropoiesisOxidative Stress5-Aminolevulinate Synthetasebeta-ThalassemiaFemaleGene Expression Regulation, EnzymologicGene Knockdown TechniquesHemeHeme Oxygenase-1HumansK562 CellsMaleOxidoreductases Acting on CH-CH Group DonorsPeroxiredoxinsReactive Oxygen Species5-Aminolevulinate SynthetaseALAS2 protein, humanbiliverdin reductaseHemeHeme Oxygenase-1Oxidoreductases Acting on CH-CH Group DonorsPeroxiredoxinsPRDX2 protein, humanReactive Oxygen Species

Identifiers

PMID21750082
PMCPMC3208676
OpenAlexW2026372267

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.